Skip to main content
. 2011 Jun 15;3(6):39. doi: 10.1186/gm255

Table 1.

Patient characteristics in genetic sub-study participants versus non-participants

Consented to use of DNA

Yes (n = 3,484) No (n = 856) P-value
Demographics
 Age 58.9 ± 12.2 59.8 ± 12.7 0.038
 White/Caucasian race 2,342 (67.4%) 573 (67.3%) 0.981
 Male 2,347 (67.4%) 551 (64.4) 0.095
 Language 0.293
  English 3,353 (98.4%) 823 (97.9%)
  Spanish 55 (1.6%) 18 (2.1%)
  Missing 76 15
 Ethnicity 0.870
  Hispanic/latino 217 (6.4%) 54 (6.6%)
  Non-hispanic/latino 3,175 (93.6%) 770 (93.4%)
  Unknown 92 32
 Low social support 612 (18.3%) 109 (13.1%) < 0.001
  Missing 133 23
 REALM-R score ≤ 6 844 (28.5%) 170 (28.1%) 0.823
 NA, missing, or unknown 423 250
Socio-economic status
 Completed high school 2,764 (79.8%) 656 (76.9%) 0.058
 History of avoiding medical care due to cost 904 (26.5%) 184 (21.7%) 0.004
 End-of-month financial situation <0.001
  Some money left over 1,380 (40.4%) 397 (47.3%)
  Just enough to make ends meet 1,297 (37.9%) 295 (35.1%)
  Not enough to make ends meet 741 (21.7%) 148 (17.6%)
Medical history
 BMI 29.8 ± 10.2 29.0 ± 6.5 0.025
 Chronic heart failure 302 (8.7%) 70 (8.2%) 0.646
 Dyslipidemia 1,721 (49.4%) 407 (47.5%) 0.332
 Hypertension 2,318 (66.5%) 575 (67.2%) 0.722
 Prior MI 710 (20.4%) 202 (23.6%) 0.038
 Cancer 250 (7.2%) 62 (7.2%) 0.946
 Diabetes 1,068 (30.7%) 268 (31.3%) 0.710
Presentation
 Final MI diagnosis 0.568
 STEMI 1,475 (42.3%) 383 (44.7%)
 NSTEMI 1,979 (56.8%) 465 (54.3%)
 BBB/uncertain type 7 (0.2%) 2 (0.2%)
 Patient not diagnosed with MI 23 (0.7%) 6 (0.7%)
 Peak troponin 29.3 ± 76.6 25.6 ± 58.1 0.187
Medications (arrival and discharge)
 Aspirin on arrival 1,431 (41.1%) 353 (41.2%) 0.930
 Beta blocker at DC 3,109 (89.7%) 776 (91.4%) 0.132
 Thienopyridine on Arrival 433 (12.4%) 113 (13.2%) 0.541
 Statin at DC 3,030 (87.4%) 744 (87.6%) 0.852
Processes of care
 In-hospital cardiac catheterization 3,222 (92.5%) 777 (90.8%) 0.096
 In-hospital revascularization 2,498 (71.7%) 618 (72.2%) 0.772
 Enrolled in other study 326 (9.4%) 70 (8.2%) 0.283
 Length of stay 5.6 ± 6.4 6.0 ± 8.90 0.207
Health Status
 SAQ Quality of Life score 62.2 ± 23.6 67.5 ± 23.3 < 0.001
 SAQ Angina Stability score 43.8 ± 21.8 47.1 ± 20.6 < 0.001
 SAQ Physical Limitation score 85.0 ± 22.6 88.4 ± 19.6 < 0.001
 SF-12v2 Mental Component score 49.6 ± 11.5 50.0 ± 11.6 0.411
 SF-12v2 Physical Component score 42.0 ± 12.4 42.8 ± 12.5 0.094
 PHQ-9 depression severity <0.001
  Not clinically depressed 1,763 (54.4%) 539 (65.7%)
  Mild depression 831 (25.6%) 170 (20.7%)
  Moderate depression 376 (11.6%) 72 (8.8%)
  Moderately severe depression 191 (5.9%) 27 (3.3%)
  Severe depression 81 (2.5%) 12 (1.5%)
  Missing 242 36
GRACE 6 m Mortality Risk score 100.0 ± 29.81 103.0 ± 31.1 0.008

Baseline patient characteristics are listed in the left-most column, with the quantities for those that participated in the genetic study, those that did not, and the P-value for difference between the two in the subsequent three columns. Categorical variables are shown as the number of subjects with that characteristic, followed by the proportion this represents (percentage) in parentheses. For variables that have subcategories, each subcategory and the number and proportion of subjects in that group is shown. Continuous variables are shown as the mean ± the standard deviation. Categorical variables were compared using chi-square or Fisher's exact test. Continuous variables were compared using Student's t-test. BBB, bundle branch block; BMI, body mass index; DC,; GRACE, Global Registry of Acute Coronary Events; NA, not applicable; NSTEMI, non-ST elevation myocardial infarction; PHQ, Patient Health Questionnaire; SAQ, Seattle Angina Questionaire; SF, Short Form; STEMI, ST elevation myocardial infarction.